ADVENT ATOPIC DERMATITIS ADVANCES IN TYPE 2 IMMUNE DISEASES Trademark

Trademark Overview


On Friday, April 13, 2018, a trademark application was filed for ADVENT ATOPIC DERMATITIS ADVANCES IN TYPE 2 IMMUNE DISEASES with the United States Patent and Trademark Office. The USPTO has given the ADVENT ATOPIC DERMATITIS ADVANCES IN TYPE 2 IMMUNE DISEASES trademark a serial number of 87876785. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 5, 2025. This trademark is owned by Sanofi Biotechnology. The ADVENT ATOPIC DERMATITIS ADVANCES IN TYPE 2 IMMUNE DISEASES trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, atopic dermatitis, in the fields of immunology and inflammatory diseases
advent atopic dermatitis advances in type 2 immune diseases

General Information


Serial Number87876785
Word MarkADVENT ATOPIC DERMATITIS ADVANCES IN TYPE 2 IMMUNE DISEASES
Filing DateFriday, April 13, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 5, 2025
Registration Number5683899
Registration DateTuesday, February 26, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements


Goods and ServicesEducational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, atopic dermatitis, in the fields of immunology and inflammatory diseases
Description of MarkThe mark consists of the stylized wording "ADVENT" below two slightly offset chevrons facing the opposite direction. The letters "AD" appear in a dark orange, and the letters "VENT" appear in a light orange. The wording "ATOPIC DERMATITIS" appears in a stylized light orange font over the wording "VENT". The left-pointing chevron is shaded light gray to dark gray from left to right, and the right-pointing chevron is shaded dark orange to light orange from left to right. A shadow in dark gray between the two chevrons gives the illusion of depth. The stylized wording "ADVANCES IN TYPE 2 IMMUNE DISEASES" appears in light gray below the wording "ADVENT".
Pseudo MarkADVENT ATOPIC DERMATITIS ADVANCES IN TYPE TWO IMMUNE DISEASES; ADVENT ATOPIC DERMATITIS ADVANCES IN TYPE TO IMMUNE DISEASES
Indication of Colors claimedThe color(s) light orange, dark orange, light gray, and dark gray is/are claimed as a feature of the mark.
NOT AVAILABLE"ATOPIC DERMATITIS ADVANCES IN TYPE 2 IMMUNE DISEASES"

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 5, 2025
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi Biotechnology
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Party NameSanofi Biotechnology
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Party NameSanofi Biotechnology
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Trademark Events


Event DateEvent Description
Wednesday, July 25, 2018ASSIGNED TO EXAMINER
Tuesday, April 17, 2018NEW APPLICATION ENTERED
Sunday, April 22, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 24, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, August 2, 2018NON-FINAL ACTION WRITTEN
Thursday, August 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 2, 2018NON-FINAL ACTION E-MAILED
Thursday, August 30, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 12, 2018ASSIGNED TO LIE
Wednesday, January 23, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Monday, February 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 5, 2025CANCELLED SEC. 8 (6-YR)
Thursday, December 13, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, September 14, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED